rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Novartis India Ltd.

500672 NOVARTIND Group (B)

01 Oct,15:42
1107.20
-11.95 (-1.07%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Novartis India Ltd.

BUYSELL

14,828 1,119.15 1,150.45 - 1,095.00 1,248.00 - 599.95 2,734.79
NSE | BSE

Novartis India Ltd.

NOVARTIND

25 Oct,15:57
672.25
-17.10 (-2.48%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Novartis India Ltd.

BUYSELL

11,837 689.35 698.20 - 668.35 909.00 - 537.00 80.54

News for Novartis India Ltd.

Natco Pharma...
Natco Pharma Files Generic Cancer Drug Application with USFDA - Business News
Natco Pharma has submitted an ANDA to the USFDA for a generic version of Novartis' Tabrecta, a cancer drug. The company expects to be eligible for 180 days of marketing exclusivity.
Aug 29, 2024 17:10
Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
Alembic Pharma...
Alembic Pharma Gets USFDA Nod for Heart Failure Drug
Alembic Pharmaceuticals receives USFDA approval to market a generic medication for heart failure, a therapeutically equivalent version of Novartis's Entresto tablets.
May 30, 2024 16:20
India's Growing...
India's Growing Appeal for Clinical Trials: Pharma Leaders Speak
Pharma industry leaders highlight India's rising attractiveness for clinical trials, citing recent reforms and a robust healthcare infrastructure. Learn about the factors driving this trend.
Apr 27, 2024 19:35
Novartis India Strategic Review: Impact on Listed Business
Novartis AG announces a strategic review of Novartis India Ltd, its listed subsidiary, assessing its 70.68% shareholding. The review does not impact Novartis Healthcare Pvt Ltd.
Feb 16, 2024 22:31

More News for Novartis India Ltd. »

(Rs. Crore)

Financial Results of Novartis India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales335.07378.74399.87381.35438.25
Operating profit65.2665.0827.1126.7912.03
Interest1.491.754.837.686.39
Gross profit125.45121.4455.4752.2041.78
EPS (Rs)34.5241.88-1.518.474.08

See more in Research Center »

News for Pharmaceuticals and health care

Real Estate...
Real Estate Investment Soars 45% in Q3 2024: Colliers
Institutional investments in Indian real estate surged to USD 1.15 billion in July-September, driven by strong demand for premium homes and offices. Colliers reports office segment attracting USD...
Oct 02, 2024 11:02
India's Potential...
India's Potential as Green Shipbuilding Hub: Maritime Expert
India's government focus on alternative fuels and renewable energy positions it as a potential hub for green shipbuilding, according to maritime expert Cristina Saenz de Santa Maria of DNV.
Oct 02, 2024 10:45
UP Govt....
UP Govt. Announces Cinema Hall Scheme: Incentives & Industry Status for IT
Uttar Pradesh government approves a scheme to revive cinema halls, upgrade existing ones, and provide incentives. IT/ITES sector also gets industry status.
Oct 01, 2024 22:23
Plutus Wealth...
Plutus Wealth Buys SpiceJet Shares for Rs 50 Crore
Plutus Wealth Management has acquired a 0.58% stake in SpiceJet for Rs 50 crore through an open market transaction. The shares were bought at an average price of Rs 66.70 apiece.
Oct 01, 2024 22:13
Odisha to Host...
Odisha to Host Ambassadors' Meet Ahead of Biz Summit
Odisha government to host a meeting of ambassadors in Delhi to showcase its industrial ecosystem and investment opportunities ahead of the Utkarsh Odisha: Make in Odisha Conclave 2025.
Oct 01, 2024 22:04

More News »

Top News

Real Estate...
Real Estate Investment Soars 45% in Q3 2024: Colliers
Institutional investments in Indian real estate surged to USD 1.15 billion in July-September, driven by strong demand for premium homes and offices. Colliers reports office segment attracting USD...
Oct 02, 2024 11:02
India's Potential...
India's Potential as Green Shipbuilding Hub: Maritime Expert
India's government focus on alternative fuels and renewable energy positions it as a potential hub for green shipbuilding, according to maritime expert Cristina Saenz de Santa Maria of DNV.
Oct 02, 2024 10:45
Mahatma Gandhi Jayanti: Markets Closed
Indian stock, currency, and commodities markets will be closed on Wednesday, October 2nd, in observance of Mahatma Gandhi Jayanti.
Oct 02, 2024 09:48
EU Deforestation Regulation: Concerns and Support
The EU's Deforestation Regulation sparks debate, with countries, businesses, and environmental groups expressing concerns and support. Learn about the EUDR's impact on trade and forest conservation.
Oct 02, 2024 09:02
UP Cabinet Approves Self-Employment Scheme for Youths && Private Universities
Uttar Pradesh cabinet approves a self-employment scheme for youths with loan subsidies for microenterprises && service sector projects. Two new private universities in Mathura &&...
Oct 01, 2024 22:49

More Top News »

Report Card

PE Ratios
32.08
EPS (Rs.)
34.52
Sales (Rs. Cr)
92.29
Face Value (Rs.)
5
Net Profit Margin (%)
25.42
Last Bonus
1:2
Last Dividend(%)
500
Return on Average Equity
11.43

Compare 'Novartis India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,926.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,757.90
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,068.35
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,195.75
  • Compare
  • Max Healthcare Institute Ltd.
  • 985.45
  • Compare
  • Alkem Laboratories Ltd.
  • 6,060.90
  • Compare
  • Divi's Laboratories Ltd.
  • 5,446.20
  • Compare

Most Active

  • Change (Rs.)
  •  

Novartis India Ltd. performance snapshot

If you had invested Rs.  in Novartis India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Novartis India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Novartis India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close